Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for JANUX THERAPEUTICS, INC. Common Stock (JANX).
- Disclosed ownership: 10%.
- Date of event: 31 Oct 2025.
JANUS HENDERSON GROUP PLC - 31 Oct 2025 SCHEDULE 13G/A Report for JANUX THERAPEUTICS, INC. Common Stock (JANX)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Symbol
- JANX
- Shares outstanding
- 60,339,490 shares
- Disclosed Ownership
- 6,033,949 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Nov 2025, 12:10:55 UTC
- Date of event
- 31 Oct 2025
- Previous filing
- 14 Aug 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 10% ownership in JANUX THERAPEUTICS, INC. Common Stock (JANX) on 31 Oct 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 07 Nov 2025, 12:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10% | 6,033,949 | 0 | 6,033,949 | Kristin Mariani | Head of North America Compliance, CCO |